You are on page 1of 10

Raja Sundararajan et al / Int. J.

of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

IJPAR |Volume 2 | Issue 4 | Oct - Dec-2013 ISSN: 2320-2831

Available Online at: www.ijpar.com

[Research article]
Analytical method development and validation for residual solvent of
Diltiazem hydrochloride extended release capsule by Gas chromatography
*
Raja Sundararajan, Christopher Vasanth Kumar, Jayaveera.
Gitam institute of Pharmacy, Gitam university, visakhapatnam -530045, Andrapradesh, India.

ABSTRACT
Residual solvents are organic volatile chemicals that are either used or produced during the manufacture of
active pharmaceutical ingredients, excipients, and drug products. Organic solvents such as di ethyl ether, N
heptane, acetone, methyl acetate, tertiary - butyl alcohol, iso-propyl alcohol, ethanol , toluene, Nbutanol, and n-
butyl acetate frequently used in pharmaceutical industry for the manufacturing of drug product Gas
Chromatography method for the determination of residual solvent of Diltiazem Hydrochloride Extended
Release Capsulesfor iso-propyl alcoholhas been carried out using this method.this method utilizedPerkin Elmer
clarus 580 GC Turbomatrix 40 Headspace sampler and DB-624, 30 m x 0.530 mm ID, 3.0 µm column was used
with flame ionizationdetector (FID). The GC method for the determination of residual solvent of Diltiazem
Hydrochloride Extended Release Capsules was validated. The method was found to be specific, precise, linear,
accurate, rugged, robust and suitable for its intended use.
Keywords: Diltiazem Hydrochloride, iso-propyl alcohol, ICH, validation.

INTRODUCTION
Diltiazem is a calcium ion influx inhibitor (slow Harmonization (ICH) [1-2]. General chapter in USP
[3]
channel blocker or calcium antagonist). .Gas chromatography method for the
Chemically, diltiazem hydrochloride is 1, 5- determination of residual solvents[4-5]. Analytical
Benzothiazepin-4(5H) one, 3-(acetyloxy)-5-[2- Methods for Residual Solvents Determination in
(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxy Pharmaceutical Products and excipients[6-7].
phenyl)-, mono hydrochloride, (+)-cis-. Its Chromatographic methods for residual solvents
molecular formula is C22H26N2O4S HCl and its analysis for iso propyl alcohol[8-9]. A review on
molecular weight is 450.99. Diltiazem produces its GC-MS and Method Development and
antihypertensive effect primarily by relaxation of Validation[10]. Since this drug is official in
vascular smooth muscle with a resultant decrease in pharmacopoeia only in dissolution method.No
peripheral vascular resistance. The magnitude of previous GC-FID method for the determination and
blood pressure reduction is related to the degree of quantification of Diltiazem Hydrochloride
hypertension; thus hypertensive individuals Extended Release Capsules in literature. Therefore,
experience an antihypertensive effect, whereas the purpose of this investigation was to develop
there is only a modest fall in blood pressure in and validate a method using a simple, rapid,
normotensives. International Conference on sensitive, specific, precise, linear, accurate, rugged,
robust GCFID method.

194
*Corresponding author: Raja Sundararajan
E-mail address: sraja61@gmail.com
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

MATERIALS AND METHOD


Reagents/chemicals
Isopropyl alcohol : GC/HPLC/GR
Dimethyl sulphoxide : HPLC Grade

GC conditions
Instrument : Gas chromatography with Headspace
Column : DB624, 30m x 0.530 mm ID x 3.0 µm
Carrier gas : Nitrogen
Linear velocity : 35 cm/sec
Detector : 240°C, FID
Range : 1
Attenuation : 4
Injector temperature : 200 °C
Oven temperature program :
Temperature : 40°C
Hold time ‘1’ : 0°C/min
Rate temp : 10°C/min
Hold temp : 220°C
Hold Time ‘2’ : 5 min

Run time : 23 min


Gas flow : Constant velocity
Split : 1:20
Hydrogen : 45 mL/min
Zero Air : 450 mL/min

Condition for Head Space Sampler


Vial temperature : 100 °C
Needle temperature : 110 °C
Transfer line temperature : 120 °C
Injection volume : 0.06 mL
Thermostat : 15 min
High pressure inject : on
Head space mode : constant
Carrier gas pressure : 15 psi
Vial pressurization : 4 min
Withdraw time : 0.2 min
GC cycle time : 35 min

Solution preparation mg of Isopropyl alcohol (IPA) dilute to volume


Blank solution with Dimethyl sulphoxide and mix well.
Transfer 4.0 mL of Dimethyl sulphoxide in
headspace vial and seal it using vial crimper. Standard solution
Transfer 25.0 mL of standard stock solution into
Standard stock solution 100 mL volumetric flask, dilute to volume with
To a 100.0 mL volumetric flask containing 20.0 Dimethyl sulphoxide and mix.
mL of Dimethyl sulphoxide, transfer about 250.0 Transfer 4.0 mL of the standard solution into a
head space vial, and seal it using vial crimper.

195
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

Test solution mL of Dimethyl sulphoxide and seal it using vial


Crush the pellets in to fine powder. Transfer 500 crimper.
mg of powdered sample in a headspace vial. Add 4

LOD, LOQ and retention time data*

Name LOD (ppm) LOQ (ppm)


Isopropylalcohol
25 80
alcohol

*LOD, LOQ data incorporated after method validation.

Calculation standard solution.


Isopropyl CS : Concentration of standard solution
AT CS P in mg/mL
alcohol content = x x x 106
CT : Concentration of sample solution in
in ppm AS CT 100
mg/mL
Where, P : Percentage purity of standard.
AT : Area of Isopropyl alcohol peak in
the chromatogramof sample
solution.
AS : Average area of Isopropyl alcohol
peak in the chromatogram of

RESULTS AND CONCLUSIONS Ruggedness of the method was verified by


PRECISION analysing the six samples spiked with residual
SYSTEM PRECISION solvent at specification level from the same batch
Six replicate injections of standard solution were which was used for method precision as per test
injected. The mean and percentage relative method by different analyst, different lot no. of
standard deviation (% RSD) for peak areas were column, and different instrumentation different
calculated. The results are tabulated in table - 1. day. The content of residual solventswas
determined. Calculated percentage relative standard
deviation (% RSD) for residual solventin six
Acceptance criteria
samples and also calculated overall percentage
Percentage relative standard deviation (% RSD) for
relative standard deviation (% RSD) for ruggedness
peak areas is not more than 10.0
results with the method precision results. The
results are tabulated in table-3.
METHOD PRECISION
Six samples of 360 mg capsuleswere prepared by
Acceptance criteria
spiking the residual solvent at specification level
The percentage relative standard deviation (%
and analysed as per test method. The residual
RSD) for residual solvent contentfrom six samples
solvent content in six samples and percentage
is not more than 15.0. Overall percentagerelative
relative standard deviation (% RSD) for six results
standard deviation (%RSD) for method and
were calculated and the results are tabulated in
intermediate precision results is not more than 15.0
table-2.

Acceptance criteria SPECIFICITY


Blank, placebo, standard, sample solution and
The percentage relative standard deviation (%
sample solution spiked with residual solvent at
RSD) for content of residual solvent from six
specification level were injected. The elution
samples is not more than 15.0.
pattern in blank and placebo observed. The
retention time of analyte peak from standard
INTERMEDIATE PRECISION solution and sample (spiked) are compiled in table-
(RUGGEDNESS)

196
197
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

4. Refer figure 2 to 6 for the chromatograms of ACCURACY (RECOVERY)


blank, placebo, standard, sample and spiked sample Known amount of residualsolvent spiked with
sample at about LOQ, 100% and 150% of
Acceptance criteria specification limit. The percentage recovery was
Observe the elution of peak pattern in the blank and calculated from the amount found and actual
placebo. amount added. The results are tabulated in table - 7.
$- Refer retention time for standard and sample
solution from method precision experiment. Acceptance criteria
Percentage recovery at each level is in between
LIMIT OF DETECTION AND LIMIT OF 85.0 and 115.0
QUANTITATION Percentage relative standard deviation (%RSD) is
(LOD and LOQ) not more than 15.0 at each level.
The limit of detection (LOD) and limit of
quantitation (LOQ) was determined for Isopropyl RANGE
alcoholby signal to noise ratio method by using the Range inferred from the data of linearity, accuracy
formula. and precision experiments.
Signal to noise ratio (S/N) = 2H/h
H - Height of analyte ROBUSTNESS
h - Height of noise Robustness of the method was verified by
LOQ value was verified by giving six replicate deliberately varying the following condition.
injections of solution containing Isopropyl alcohol. i) By changing the flow rate by  10%.
LOD and LOQ values are summarized in table -5a. System suitability was evaluated and residual
The percentage relative standard deviation (% solvent spiked sample was analysed in triplicate.
RSD) calculated for peak areas and tabulated in Calculated cumulative percentage relative standard
table-5b deviation (% RSD) for each condition and method
precision data. The results tabulated in table-8. The
Acceptance criteria system suitability parameters are tabulated in table-
Signal to noise ratio 10:1 at the level of LOQ and 9.
2:1 or 3:1 at the level of LOD.
The percentage relative standard deviation (% Acceptance criteria
RSD) for peak areas at LOQ level is not more than Overall percentage relative standard deviation (%
15.0 RSD) for each change condition and method
precision results is not more than ± 15.0
LINEARITY
Linearity for Isopropyl alcohol was performed SUMMARY OF SYSTEM SUITABILITY
from about LOQ to 150 % level. A graph was System suitability was evaluated by injecting
plotted with concentration (in ppm) on x-axis and standard solution during various days of validation.
peak areas on y-axis. Slope, y-intercept, correlation The percentage relative standard deviation (%
coefficient and residual sum of squares (RSS) were RSD) for the peak areas were verified. The results
determined. The results are tabulated in table -6 are tabulated in table – 9
graphically represented in figure- 1
Acceptance Criteria
Acceptance criteria The percentage relative standard deviation (%
The correlation coefficient (r-value) value is not RSD) for the six injections of standard is not more
less than 0.97 than 10.0

197
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

TABLES
TABLE – 1-SYSTEM PRECISION

Injection No. Peak area


1 187952
2 191760
3 189915
4 188706
5 188366
6 192441
Mean 189857
% RSD 1.0

TABLE – 2-METHOD PRECISION

Sample No. Isopropyl alcohol (ppm)


1 6125
2 6284
3 6171
4 6097
5 6145
6 6118
Mean 6157
% RSD 1.1

TABLE – 3-INTERMEDIATE PRECISION

Sample No. Isopropyl alcohol (ppm)


Analyst 1 Analyst 2
1 6125 6280
2 6284 6101
3 6171 6266
4 6097 6205
5 6145 6345
6 6118 6487

Mean 6157 6281


Percentage relative 1.1 2.1
standard deviation (%
RSD)
Overall average 6219

Over all Percentage 1.9


relative standard deviation
(% RSD)

198
199
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

TABLE – 4-SPECIFICITY

Peak Name Sample type RT (min.) $

Isopropyl alcohol Standard 3.159


Spiked sample 3.157

TABLE -5a-SUMMARY OF LOD AND LOQ VALUES

Name LOD LOQ

ppm S/N ppm S/N

Isopropyl alcohol 25 27 80 68

TABLE -5b-PRECISION AT LOQ

Injection No. Peak area


1 3018
2 2924
3 2976
4 2949
5 2966
6 2994
Mean 2971
% RSD 1.1
S/N - Signal to noise ratio

TABLE –6-LINEARITY OF ISOPROPYL ALCOHOL

Level (%) Concentration in ppm Peak area


LOQ 80.0384 2956
25 1250.6000 45189
50 2501.2000 90831
75 3751.8000 138527
100 5002.4000 185430
125 6253.0000 237433
150 7503.6000 285464
Slope 38.1514
y-intercept -2739.8875
Correlation coefficient 0.99978
Residual sum of squares 17614806.9169

199
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

TABLE –7-ACCURACY OF ISOPROPYL ALCOHOL


Level Amount found in µg Actual amount added in µg % Recovery
Mean % RSD

Level - 1 70.7097 79.9584 88.4 95.7 12.9


(LOQ)
70.9501 79.9584 88.7
87.8531 79.9584 109.9
Level - 2 5184.0542 4997.3976 103.7 105.3 1.9
(100%)
5377.5980 4997.3976 107.6

5233.5884 4997.3976 104.7


Level - 3 7710.7255 7496.0964 102.9 101.3 1.4
(150%)
7526.1539 7496.0964 100.4
7544.0716 7496.0964 100.6

TABLE –8-ROBUSTNESS
S.No. Method precision Flow rate (31.5 cm/sec) Flow rate
(38.5cm/sec)
1 6125 5654 5600

2 6284 5654 5605


3 6171 5795 5765

4 6097 - -
5 6145 - -
6 6118 - -
Mean 6157 - -
%RSD 1.1 - -
Overall Mean - 6005 5990

Overall %RSD - 4.0 4.3

TABLE -9-SUMMARY OF SYSTEM SUITABILITY


S.No Name of Experiment % RSD
1 System precision and 1.0
Method precision
2 Specificity and Robustness 0.6
3 Robustness 0.6
(Flow Rate – 38.5 cm/Sec)

4 Robustness 1.0
(Flow Rate – 31.5 cm/Sec)
5 LOQ, LOD, Linearity and Accuracy 0.8
6 Intermediate Precision 1.8

200
201
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

FIGURES
Figure 1: Linearity plot for Isopropyl alcohol

300000 Isopropyl alcohol


250000
200000
Area

150000
100000
50000
0
0.0000 2000.0000 4000.0000 6000.0000 8000.0000
Concentration µg/mL

Figure - 2: Chromatogram of blank

Figure - 3: Chromatogram of placebo

201
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

Figure - 4: Chromatogram of standard

Figure - 5: Chromatogram of sample (unspiked)

Figure - 6: Chromatogram ofspiked sample

202
203
Raja Sundararajan et al / Int. J. of Pharmacy and Analytical Research Vol-2(4) 2013 [194-203]

ACKNOWLEDGEMENTS chromatographic method for estimation of residual


The authors are grateful to piramal health care Ltd, solvents in Diltiazem Hydrochloride Extended
India. For providing Diltiazem hydrochloride as a Release Capsule drug product. The developed
gift sample. method is specific, precise, linear, accurate, rugged,
robust and suitable for its intended use.
CONCLUSION
This study presents a simple and validated Gas

REFERENCES
[1] ICH Expert Working Group. Impurities: Guideline for Residual solvents. Q3C[R5],
2011.
[2] ICH. Validation of Analytical Procedures, Text and Methodology, Q2 (R1), 2005.
[3] USP <467> Residual solvents.
[4] Marie-JoséeRocheleau, MélanieTitley, Julie Bolduc, Measuring residual solvents in pharmaceutical
samples using fast gas chromatography techniques, Journal of Chromatography B, 805, 2004, 77–86.
[5] Chusena Narasimharaju Bhimanadhuni and Devala Rao Garikapati, Development and validation of gas
chromatography method for the determination of residual solvents in Mirabegron,Der PharmaChemica,
2013, 5(1):55-60.
[6] Katarzyna Grodowska and Andrzej Parczewski, Analytical Methods For Residual Solvents
Determination In Pharmaceutical Products, Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 67
No.1, 2010:13-26.
[7] RohitkumarM.Yadav and KapilPatil, Development and Validation of Gas Chromatographic Analytical
Method for Estimation of Residual Solvents in Excipients (Klucell, Triacetan, HPMC), International
Journal of Research in Pharmaceutical and Biomedical Sciences,Vol. 4 (2) Apr– Jun 2013, 618-623.
[8] Praveen Kumar Baliyan, R.P. Singh and SaurabhArora, Simultaneous Estimation of Residual Solvents
(Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID, Asian Journal of
Chemistry, Vol. 21, No. 3 (2009), 1739-1746.
[9] S.B. Puranik, Varun R. Pawar, N. Lalitha, P.N. Sanjay Pai and G.K. Rao, Gas chromatographic
methods for residual solvents analysis, Oriental Journal of Chemistry, Vol. 24(1), 2008, 529-536.
[10] Lakshmi Hima Bindu M.R, Angala Parameswari S,Gopinath C,A Review on GC-MS and Method
Development and Validation, International Journal of Pharmaceutical Quality Assurance 2013; 4 ( 3) ;
42-51.

*******************************

203

You might also like